Clinical Trial Update: Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

View source ↗

Summary

A completed post-marketing surveillance study in Japan evaluating Julina for postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Julina

Snippet

Sponsor: Bayer | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED